These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans. Limdi NA; Beasley TM; Crowley MR; Goldstein JA; Rieder MJ; Flockhart DA; Arnett DK; Acton RT; Liu N Pharmacogenomics; 2008 Oct; 9(10):1445-58. PubMed ID: 18855533 [TBL] [Abstract][Full Text] [Related]
9. New genetic variant that might improve warfarin dose prediction in African Americans. Schelleman H; Brensinger CM; Chen J; Finkelman BS; Rieder MJ; Kimmel SE Br J Clin Pharmacol; 2010 Sep; 70(3):393-9. PubMed ID: 20716240 [TBL] [Abstract][Full Text] [Related]
10. Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health record. Ramirez AH; Shi Y; Schildcrout JS; Delaney JT; Xu H; Oetjens MT; Zuvich RL; Basford MA; Bowton E; Jiang M; Speltz P; Zink R; Cowan J; Pulley JM; Ritchie MD; Masys DR; Roden DM; Crawford DC; Denny JC Pharmacogenomics; 2012 Mar; 13(4):407-18. PubMed ID: 22329724 [TBL] [Abstract][Full Text] [Related]
11. Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. Limdi NA; Wiener H; Goldstein JA; Acton RT; Beasley TM Blood Cells Mol Dis; 2009; 43(1):119-28. PubMed ID: 19297219 [TBL] [Abstract][Full Text] [Related]
12. The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans. Perera MA; Gamazon E; Cavallari LH; Patel SR; Poindexter S; Kittles RA; Nicolae D; Cox NJ Clin Pharmacol Ther; 2011 Mar; 89(3):408-15. PubMed ID: 21270790 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms. Nagai R; Ohara M; Cavallari LH; Drozda K; Patel SR; Nutescu EA; Perera MA; Hernandez W; Kaneko N; Hibiya M; Takahashi H Pharmacogenomics; 2015; 16(3):217-25. PubMed ID: 25712185 [TBL] [Abstract][Full Text] [Related]
14. Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array. Liu N; Irvin MR; Zhi D; Patki A; Beasley TM; Nickerson DA; Hill CE; Chen J; Kimmel SE; Limdi NA Pharmacogenomics; 2017 Jul; 18(11):1059-1073. PubMed ID: 28686080 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation. Syn NL; Lee SC; Brunham LR; Goh BC Pharmacogenet Genomics; 2015 Oct; 25(10):491-500. PubMed ID: 26230382 [TBL] [Abstract][Full Text] [Related]
16. Race influences warfarin dose changes associated with genetic factors. Limdi NA; Brown TM; Yan Q; Thigpen JL; Shendre A; Liu N; Hill CE; Arnett DK; Beasley TM Blood; 2015 Jul; 126(4):539-45. PubMed ID: 26024874 [TBL] [Abstract][Full Text] [Related]
17. Genetic and clinical predictors of warfarin dose requirements in African Americans. Cavallari LH; Langaee TY; Momary KM; Shapiro NL; Nutescu EA; Coty WA; Viana MA; Patel SR; Johnson JA Clin Pharmacol Ther; 2010 Apr; 87(4):459-64. PubMed ID: 20072124 [TBL] [Abstract][Full Text] [Related]